Can Natriuretic Peptides be Used to Guide Therapy?

Area of Science:

• Cardiology
• Biomarkers
• Clinical Trials

Background:

• Heart failure (HF) management remains a clinical challenge.
• Natriuretic peptides (NPs) are biomarkers associated with cardiac strain.
• The role of NP-guided therapy in HF is under investigation.

Purpose of the Study:

• To review the evidence on using NP concentrations to guide outpatient heart failure therapy.
• To evaluate the impact of NP-guided treatment on HF outcomes.
• To synthesize findings from clinical trials, meta-analyses, and guidelines.

Main Methods:

• Systematic review of prospective clinical trials and meta-analyses.
• Analysis of international cardiology guidelines (ESC, ACC/AHA).
• Focus on randomized controlled trials investigating NP-targeted HF management.

Main Results:

• Clinical trials investigating NP-guided HF therapy have yielded conflicting results.
• Collectively, data suggest NPs may aid in managing HF morbidity and mortality.
• International guidelines acknowledge the potential utility of NPs in HF care.

Conclusions:

• NP-guided outpatient HF management shows promising but inconclusive results.
• Further well-designed randomized controlled trials, such as GUIDE-IT, are essential.
• Confirmation is needed to establish the definitive role of NP-guided therapy in HF.